Article Information
History
- December 11, 2020.
Article Versions
- Version 1 (December 11, 2020 - 03:02).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jorg Taubel1,2,3,*,
- Samuel Thomas Cole2,
- Christopher S. Spencer1,
- Anne Freier1,
- Dorothée Camilleri2 and
- Ulrike Lorch2
- 1Richmond Research Institute, 1a Newcomen Street, London, SE1 1YR, UK
- 2Richmond Pharmacology Ltd, 1a Newcomen Street, London, SE1 1YR, UK
- 3St. George’s, University of London, Cranmer Terrace, Tooting, London, SW17 0RE, UK
- ↵*Correspondence to : J Taubel, j.taubel{at}richmondpharmacology.com
Posted December 11, 2020.
Why the SARS-CoV-2 antibody test results may be misleading: insights from a longitudinal analysis of COVID-19
